Riskpilot← Back to searchSign inGet full accessAmnionkliniken i Skåne AB
ABActiveOrg 5592052525Sockerkokaregatan 19Nursing and midwifery activities · NACE 8694Est. 20195-9 employees
Revenue 2025
SEK 4,6M
+13% vs 2024
EBITDA margin
6.3%
+65% vs 2024
Equity ratio
44.6%
Financial strength
Net profit 2025
SEK 303K
+228% vs 2024
| Revenue | SEK 4,6M | +13% |
| EBITDA | SEK 288K | +65% |
| Net profit | SEK 303K | +228% |
| Total assets | SEK 989K | -30% |
| Equity | SEK 441K | +31% |
| Employees | — | — |
Legal name
Amnionkliniken i Skåne AB
Org number
5592052525
Legal form
Aktiebolag
NACE code
8694 · Nursing and midwifery activities
Founded
10 maj 2019
Share capital
SEK 50 000
Employees
5-9
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva ultraljudsmottagning och förlossningsförberedande verksamhet, bemanning inom graviditetsultraljud och förlossningsvård samt därmed förenlig verksamhet.
Address
Sockerkokaregatan 19
Email
info@amnionkliniken.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 2 125 | 2 977 | 3 654 | 4 050 | 4 571 |
| Staff expenses | — | −1 672 | −1 784 | −2 225 | −2 514 |
| EBITDA | 188 | 41 | 392 | 174 | 288 |
| Depreciation & amort. | −12 | −15 | −15 | −15 | −5 |
| EBIT | 176 | 26 | 377 | 159 | 282 |
| Net financials | −13 | −11 | −9 | −32 | 84 |
| Profit before tax | 163 | 15 | 368 | 127 | 366 |
| Tax | −31 | −4 | −82 | −35 | −63 |
| Net profit | 132 | 11 | 286 | 92 | 303 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 866 | 865 | 1 011 | 1 422 | 989 |
| Equity | 159 | 159 | 445 | 338 | 441 |
| Long-term debt | 149 | 101 | 52 | 4 | 4 |
| Short-term debt | 558 | 605 | 513 | 1 081 | 545 |
| Total debt | 707 | 706 | 566 | 1 084 | 548 |
EBITDA margin
6.3%
This company
15.8%
Market median
-60% vs market
20212025
Equity ratio
44.6%
This company
38.2%
Market median
+17% vs market
20212025
Return on equity
68.8%
This company
18.4%
Market median
+274% vs market
20212025
Net profit margin
6.6%
This company
8.1%
Market median
-19% vs market
20212025
Asset turnover
4.62×
This company
1.12×
Market median
+312% vs market
20212025
Debt / equity
1.24×
This company
0.62×
Market median
-100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AV Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Deputy Board Member | 2020 | |
| Chairman | 2020 | |
| Deputy Board Member | 2022 | |
| Former (1) | ||
| Deputy Board Member | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Amnionkliniken i Skåne AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Anna Victoria Skärvad | Chief Executive Officer | 0 companies |
| Hans Kenneth Ruona | Deputy Board Member | 0 companies |
| Martina Josefina Qvennerberg | Chairman | 0 companies |
| Peter Martin Boye | Deputy Board Member | 0 companies |
| Carl Johan Faijersson | Deputy Board Member | 0 companies |